News | September 09, 2025
SPL Infusion commences commercial production of new IV fluid Infusion plant
The facility has been designed with a dual focus on efficiency and sustainability
The facility has been designed with a dual focus on efficiency and sustainability
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
This year’s edition will witness participation of over 700 Indian exporters showcasing their products and services; 500+ overseas delegates representing more than 120 countries; 20,000 domestic visitors; and 8,000+ B2B meetings
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Subscribe To Our Newsletter & Stay Updated
